ANTHIM

This brand name is authorized in United States.

Active ingredients

The drug ANTHIM contains one active pharmaceutical ingredient (API):

`1`	Obiltoxaximab UNII `29Z5DNL48C` - OBILTOXAXIMAB
	Obiltoxaximab is a monoclonal antibody that binds the protective antigen (PA) of B. anthracis. Obiltoxaximab inhibits the binding of PA to its cellular receptors, preventing the intracellular entry of the anthrax lethal factor and oedema factor, the enzymatic toxin components responsible for the pathogenic effects of anthrax toxin.
	Read more about Obiltoxaximab

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ANTHIM Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	69604-204

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.